CGREF1 modulates osteosarcoma proliferation by regulating the cell cycle through the Wnt/β-catenin signaling pathway
2024

CGREF1 and Osteosarcoma: How It Affects Cell Growth

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Wei Zicheng, Xia Kezhou, Liu Wenda, Huang Xinghan, Wei Zhun, Guo Weichun

Primary Institution: Renmin Hospital of Wuhan University

Hypothesis

CGREF1 plays a significant role in the proliferation of osteosarcoma cells through the Wnt/β-catenin signaling pathway.

Conclusion

CGREF1 is linked to increased proliferation of osteosarcoma cells and targeting it may provide a new treatment strategy.

Supporting Evidence

  • CGREF1 is highly expressed in osteosarcoma and correlates with poor prognosis.
  • Knockdown of CGREF1 reduced cell proliferation in osteosarcoma cells.
  • Overexpression of CGREF1 increased cell cycle progression and proliferation.
  • CGREF1 affects the Wnt signaling pathway, which is crucial for osteosarcoma cell growth.
  • Targeting CGREF1 may offer a novel therapeutic strategy for osteosarcoma.

Takeaway

CGREF1 helps osteosarcoma cells grow faster, and if we can block it, we might be able to slow down the cancer.

Methodology

The study used bioinformatics analysis, Western blot, immunohistochemistry, siRNA, lentivirus, plasmid technologies, and various in vitro and in vivo assays.

Potential Biases

Potential bias in sample selection and the reliance on specific cell lines for experimental validation.

Limitations

The study primarily focused on specific cell lines and may not fully represent the complexity of osteosarcoma in all patients.

Participant Demographics

The study involved human normal and osteosarcoma tissues from patients at Renmin Hospital of Wuhan University.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s10020-024-01038-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication